Alza and Abbott end co-promotion of Ditropan XL

AZA and ABT agreed to end ABT's co-promotion of Ditropan XL oxybutynin chloride to treat overactive bladder. ABT also relinquished its right of first negotiation to co-promote Concerta methylphenidate...